YD Bio reported total assets of $10.06M and total liabilities of $5.59M for the quarter ended Jun 2026. This balance sheet covers 4 quarters of results from Dec 2024 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance Sheet | Dec2024 | Jun2025 | Dec2025 | Jun2026 |
|---|---|---|---|---|
| Assets | ||||
| Current Assets | ||||
| Cash & EquivalentsCash & Equiv. | 3.13M | 0.47M | 6.01M | 2.66M |
| Cash & Current Investments | 3.13M | 0.47M | 6.01M | 2.66M |
| Receivables - NetNet Receivables | 0.09M | 0.10M | 0.17M | 0.23M |
| Receivables - OtherOther Receivables | 0.02M | 0.07M | 0.29M | 0.03M |
| Receivables | 0.10M | 0.17M | 0.47M | 0.27M |
| Inventory | 0.04M | 0.37M | 1.88M | 1.89M |
| Prepaid Assets | 0.19M | 0.39M | 1.32M | 0.78M |
| Current Assets | 3.47M | 1.40M | 9.67M | 5.59M |
| Non-Current Assets | ||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.06M | 2.99M | 0.06M | 0.05M |
| Long-Term Investments | -0.10M | |||
| Intangibles | 2.68M | 2.90M | 2.61M | 2.47M |
| Goodwill & Intangibles | 2.68M | 2.90M | 2.61M | 2.47M |
| Other Non-Current Assets | 0.63M | 1.46M | 1.43M | 1.94M |
| Non-Current Assets | 3.40M | 4.44M | 4.11M | 4.47M |
| Assets | 6.86M | 5.84M | 13.78M | 10.06M |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts Payables | 0.03M | 0.04M | 0.41M | 0.37M |
| Payables | 0.03M | 0.04M | 0.41M | 0.37M |
| Accumulated Expenses | 0.18M | 0.63M | 0.44M | 0.33M |
| Other Accumulated Expenses | 0.04M | 0.06M | 0.79M | 0.36M |
| Current Leases | 0.02M | 0.02M | 0.01M | 0.01M |
| Total Current Liabilities | 263.06M | 0.75M | 1.64M | 1.07M |
| Non-Current Liabilities | ||||
| Non-Current Deferred Tax LiabilityNon-Current Deferred Tax | 0.00M | |||
| Operating Leases | 0.01M | |||
| Other Non-Current Liabilities | 0.00M | 14.99M | 4.52M | |
| Total Non-Current Liabilities | 273.98M | 1.64M | 1.07M | |
| Total Liabilities | 273.98M | 0.75M | 16.64M | 5.59M |
| Shareholder's Equity | ||||
| Common Equity | 6.59M | 5.09M | -2.86M | 4.47M |
| Liabilities and Shareholders Equity | 6.86M | 5.84M | 13.78M | 10.06M |
| Retained Earnings | -3.84M | -10.24M | -3.54M |